---
title: Dual T cell receptor/chimeric antigen receptor engineered NK-92 cells targeting
  the HPV16 E6 oncoprotein and the tumor-associated antigen L1CAM exhibit enhanced
  cytotoxicity and specificity against tumor cells
date: '2024-04-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38659368/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240425181110&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: The human papillomavirus type 16 (HPV16) causes a large fraction of genital
  and oropharyngeal carcinomas. To maintain the transformed state, the tumor cells
  must continuously synthesize the E6 and E7 viral oncoproteins, which makes them
  tumor-specific antigens. Indeed, specific T cell responses against them have been
  well documented and CD8^(+) T cells engineered to express T cell receptors (TCRs)
  that recognize epitopes of E6 or E7 have been tested in clinical studies with promising
  ...
disable_comments: true
---
The human papillomavirus type 16 (HPV16) causes a large fraction of genital and oropharyngeal carcinomas. To maintain the transformed state, the tumor cells must continuously synthesize the E6 and E7 viral oncoproteins, which makes them tumor-specific antigens. Indeed, specific T cell responses against them have been well documented and CD8^(+) T cells engineered to express T cell receptors (TCRs) that recognize epitopes of E6 or E7 have been tested in clinical studies with promising ...